drugset / Trial / NCT06511076
A Study to Evaluate Zilucoplan Injected Subcutaneously Either by a Prefilled Syringe or an Auto-injector in Healthy Adult Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to assess the bioequivalence pharmacokinetics, safety, tolerability and device deficiencies of zilucoplan (ZLP) in healthy adult participants
Timeline
- Start
- 2024-08-05
- Primary completion
- 2024-11-26
- Completion
- 2024-11-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zilucoplan | Peptide | — | Subcutaneous |
Indications
No indication recorded.